FDA NDC Directory · JSON-LD · Markdown

Enoxaparin Sodium

NDC 68001-636 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA206834
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsENOXAPARIN SODIUM (100 mg/mL)
Marketing started20250115
Package count1

External sources

Source: openFDA. Public-domain (CC0).